129 related articles for article (PubMed ID: 38377734)
1. MicroRNAs in adult high-grade gliomas: Mechanisms of chemotherapeutic resistance and their clinical relevance.
Jegathesan Y; Stephen PP; Sati ISEE; Narayanan P; Monif M; Kamarudin MNA
Biomed Pharmacother; 2024 Mar; 172():116277. PubMed ID: 38377734
[TBL] [Abstract][Full Text] [Related]
2. Involvement of FOS-mediated miR-181b/miR-21 signalling in the progression of malignant gliomas.
Tao T; Wang Y; Luo H; Yao L; Wang L; Wang J; Yan W; Zhang J; Wang H; Shi Y; Yin Y; Jiang T; Kang C; Liu N; You Y
Eur J Cancer; 2013 Sep; 49(14):3055-63. PubMed ID: 23810250
[TBL] [Abstract][Full Text] [Related]
3. MiR-16-5p is frequently down-regulated in astrocytic gliomas and modulates glioma cell proliferation, apoptosis and response to cytotoxic therapy.
Krell A; Wolter M; Stojcheva N; Hertler C; Liesenberg F; Zapatka M; Weller M; Malzkorn B; Reifenberger G
Neuropathol Appl Neurobiol; 2019 Aug; 45(5):441-458. PubMed ID: 30548945
[TBL] [Abstract][Full Text] [Related]
4. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
[TBL] [Abstract][Full Text] [Related]
5. miR-34a repression in proneural malignant gliomas upregulates expression of its target PDGFRA and promotes tumorigenesis.
Silber J; Jacobsen A; Ozawa T; Harinath G; Pedraza A; Sander C; Holland EC; Huse JT
PLoS One; 2012; 7(3):e33844. PubMed ID: 22479456
[TBL] [Abstract][Full Text] [Related]
6. Dual inhibition of PCDH9 expression by miR-215-5p up-regulation in gliomas.
Wang C; Chen Q; Li S; Li S; Zhao Z; Gao H; Wang X; Li B; Zhang W; Yuan Y; Ming L; He H; Tao B; Zhong J
Oncotarget; 2017 Feb; 8(6):10287-10297. PubMed ID: 28055966
[TBL] [Abstract][Full Text] [Related]
7. Circulating miRNAs as Diagnostic and Prognostic Biomarkers in High-Grade Gliomas.
Wu J; Al-Zahrani A; Beylerli O; Sufianov R; Talybov R; Meshcheryakova S; Sufianova G; Gareev I; Sufianov A
Front Oncol; 2022; 12():898537. PubMed ID: 35646622
[TBL] [Abstract][Full Text] [Related]
8. Role of microRNAs Located on Chromosome Arm 10q in Malignant Gliomas.
Wolter M; Werner T; Malzkorn B; Reifenberger G
Brain Pathol; 2016 May; 26(3):344-58. PubMed ID: 26223576
[TBL] [Abstract][Full Text] [Related]
9. MiR-218-5p targets LHFPL3 to regulate proliferation, migration, and epithelial-mesenchymal transitions of human glioma cells.
Li Z; Qian R; Zhang J; Shi X
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30314994
[TBL] [Abstract][Full Text] [Related]
10. MiR-181b-5p modulates chemosensitivity of glioma cells to temozolomide by targeting Bcl-2.
Zhang X; Yu J; Zhao C; Ren H; Yuan Z; Zhang B; Zhuang J; Wang J; Feng B
Biomed Pharmacother; 2019 Jan; 109():2192-2202. PubMed ID: 30551476
[TBL] [Abstract][Full Text] [Related]
11. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y
Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539
[TBL] [Abstract][Full Text] [Related]
12. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
Conti A; Romeo SG; Cama A; La Torre D; Barresi V; Pezzino G; Tomasello C; Cardali S; Angileri FF; Polito F; Ferlazzo G; Di Giorgio R; Germanò A; Aguennouz M
Tumour Biol; 2016 Oct; 37(10):14035-14048. PubMed ID: 27495233
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-210-3p is transcriptionally upregulated by hypoxia induction and thus promoting EMT and chemoresistance in glioma cells.
Liu H; Chen C; Zeng J; Zhao Z; Hu Q
PLoS One; 2021; 16(7):e0253522. PubMed ID: 34197482
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA MAPK4 (circ-MAPK4) inhibits cell apoptosis via MAPK signaling pathway by sponging miR-125a-3p in gliomas.
He J; Huang Z; He M; Liao J; Zhang Q; Wang S; Xie L; Ouyang L; Koeffler HP; Yin D; Liu A
Mol Cancer; 2020 Jan; 19(1):17. PubMed ID: 31992303
[TBL] [Abstract][Full Text] [Related]
15. Circulating serum miR-362-3p and miR-6721-5p as potential biomarkers for classification patients with adult-type diffuse glioma.
Niemira M; Bielska A; Chwialkowska K; Raczkowska J; Skwarska A; Erol A; Zeller A; Sokolowska G; Toczydlowski D; Sidorkiewicz I; Mariak Z; Reszec J; Lyson T; Moniuszko M; Kretowski A
Front Mol Biosci; 2024; 11():1368372. PubMed ID: 38455766
[TBL] [Abstract][Full Text] [Related]
16. The miR-139-5p regulates proliferation of supratentorial paediatric low-grade gliomas by targeting the PI3K/AKT/mTORC1 signalling.
Catanzaro G; Besharat ZM; Miele E; Chiacchiarini M; Po A; Carai A; Marras CE; Antonelli M; Badiali M; Raso A; Mascelli S; Schrimpf D; Stichel D; Tartaglia M; Capper D; von Deimling A; Giangaspero F; Mastronuzzi A; Locatelli F; Ferretti E
Neuropathol Appl Neurobiol; 2018 Dec; 44(7):687-706. PubMed ID: 29478280
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
18. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.
Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y
Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression.
Jiang C; Shen F; Du J; Fang X; Li X; Su J; Wang X; Huang X; Liu Z
Biomed Pharmacother; 2018 Jan; 97():844-850. PubMed ID: 29136760
[TBL] [Abstract][Full Text] [Related]
20. miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas.
Liu J; Xu J; Li H; Sun C; Yu L; Li Y; Shi C; Zhou X; Bian X; Ping Y; Wen Y; Zhao S; Xu H; Ren L; An T; Wang Q; Yu S
Oncotarget; 2015 Oct; 6(30):29129-42. PubMed ID: 26320176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
